Serum Superoxide Dismutase Is Associated with Vascular Structure and Function in Hypertensive and Diabetic Patients

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Gómez Marcos, Manuel A ^a   Blázquez Medela, Ana M ^b   Gamella Pozuelo, Luis ^b   Recio Rodriguez, José I ^a   García Ortiz, Luis ^a   Martínez Salgado, Carlos ^b,c  

^a GERENCIA REGIONAL DE SALUD DE CASTILLA Y LEÓN   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACOUSTIC WAVE VELOCITY; DISEASES; ENZYMES; OXYGEN; RISK ASSESSMENT; STIFFNESS; WAVE PROPAGATION;

CARDIOVASCULAR ALTERATION; CAROTID INTIMA-MEDIA THICKNESS; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERTENSIVE PATIENTS; NEGATIVE CORRELATION; POSITIVE CORRELATIONS; SUPER OXIDE DISMUTASE; SUPEROXIDE DISMUTASES;

BODY FLUIDS;

8 HYDROXYDEOXYGUANOSINE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SUPEROXIDE DISMUTASE; URIC ACID; TRIACYLGLYCEROL;

ADULT; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PULSE PRESSURE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; AGED; BLOOD; CLINICAL TRIAL; MIDDLE AGED; OXIDATIVE STRESS;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULSE WAVE ANALYSIS; SUPEROXIDE DISMUTASE; TRIGLYCERIDES; URIC ACID;

EID: 84948445234     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/9124676     Document Type: Article

References (27)

1. L. Ghiadoni, S. Taddei, and A. Virdis, "Hypertension and endothelial dysfunction: therapeutic approach, " Current Vascular Pharmacology, vol. 10, no. 1, pp. 42-60, 2012.
2. E. Standl, B. Balletshofer, B. Dahl et al. , "Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: theMunich General Practitioner Project, " Diabetologia, vol. 39, no. 12, pp. 1540-1545, 1996.
3. D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei, "Endothelial dysfunction as a target for prevention of cardiovascular disease, " Diabetes Care, vol. 32, pp. S314-S321, 2009.
4. M. A. Potenza, S. Gagliardi, C. Nacci, M. R. Carratu, and M. Montagnani, "Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets, " Current Medicinal Chemistry, vol. 16, no. 1, pp. 94-112, 2009.
5. J. L. Cavalcante, J. A. C. Lima, A. Redheuil, andM. H. Al-Mallah, "Aortic stiffness: current understanding and future directions, " Journal of the American College of Cardiology, vol. 57, no. 14, pp. 1511-1522, 2011.
6. C.-C. Chen, K.-C. Hung, I.-C. Hsieh, and M.-S. Wen, "Association between peripheral vascular disease indexes and the numbers of vessels obstructed in patients with coronary artery disease, " American Journal of theMedical Sciences, vol. 343, no. 1, pp. 52-55, 2012.
7. M. Kikuya, J. A. Staessen, T. Ohkubo et al. , "Ambulatory arterial stiffness index and 24-hour ambulatory pulse pressure as predictors of mortality in Ohasama, Japan, " Stroke, vol. 38, no. 4, pp. 1161-1166, 2007.
8. H. Triantafyllidi, S. Tzortzis, J. Lekakis et al. , "Association of target organ damagewith three arterial stiffness indexes according to blood pressure dipping status in untreated hypertensive patients, " American Journal of Hypertension, vol. 23, no. 12, pp. 1265-1272, 2010.
9. M. A. Gómez-Marcos, J. I. Recio-Rodríguez, M. C. Patino-Alonso et al. , "Ambulatory arterial stiffness indices and target organ damage in hypertension, "BMCCardiovascularDisorders, vol. 12, article 1, 2012.
10. M. Shimizu and K. Kario, "Role of the augmentation index in hypertension, "Therapeutic Advances in Cardiovascular Disease, vol. 2, no. 1, pp. 25-35, 2008.
11. N. S. Dhalla, R. M. Temsah, and T. Netticadan, "Role of oxidative stress in cardiovascular diseases, " Journal of Hypertension, vol. 18, no. 6, pp. 655-673, 2000.
12. M. T. Elnakish, H. H. Hassanain, P. M. Janssen, M. G. Angelos, and M. Khan, "Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase, " Journal of Pathology, vol. 231, no. 3, pp. 290-300, 2013.
13. F. Lacy, D. T. O'Connor, and G. W. Schmid-Schonbein, "Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension, " Journal of Hypertension, vol. 16, no. 3, pp. 291-303, 1998.
14. C. R. White, T. A. Brock, L.-Y. Chang et al. , "Superoxide and peroxynitrite in atherosclerosis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 3, pp. 1044-1048, 1994.
15. M. K. Cathcart, A. K. McNally, D. W. Morel, andG. M. Chisolm III, "Superoxide anion participation in human monocytemediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin, " Journal of Immunology, vol. 142, no. 6, pp. 1963-1969, 1989.
16. T. Fukai and M. Ushio-Fukai, "Superoxide dismutases: role in redox signaling, vascular function, and diseases, " Antioxidants and Redox Signaling, vol. 15, no. 6, pp. 1583-1606, 2011.
17. G. Mancia, R. Fagard, K. Narkiewicz et al. , "2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), " Journal of Hypertension, vol. 31, pp. 1281-1357, 2013.
18. American Diabetes Association, "Diagnosis and classification of diabetes mellitus, " Diabetes Care, vol. 37, supplement 1, pp. S81-S90, 2014.
19. E. O'Brien, R. Asmar, L. Beilin et al. , "Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement, " Journal of Hypertension, vol. 23, no. 4, pp. 697-701, 2005.
20. M. A. Gómez-Marcos, J. I. Recio-Rodríguez, M. C. Patino-Alonso et al. , "Protocol for measuring carotid intima-media thickness that best correlates with cardiovascular risk and target organ damage, " American Journal of Hypertension, vol. 25, no. 9, pp. 955-961, 2012.
21. R. B. D'Agostino , R. S. Vasan, M. J. Pencina et al. , "General cardiovascular risk profile for use in primary care: the Framingham heart study, " Circulation, vol. 117, no. 6, pp. 743-753, 2008.
22. J. H. Indik, S. Goldman, and M. A. Gaballa, "Oxidative stress contributes to vascular endothelial dysfunction in heart failure, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 281, no. 4, pp. H1767-H1770, 2001.
23. M. Navab, G. M. Anantharamaiah, S. T. Reddy, B. J. Van Lenten, B. J. Ansell, and A. M. Fogelman, "Mechanisms of disease: proatherogenic HDL-An evolving field, " Nature Clinical Practice Endocrinology & Metabolism, vol. 2, no. 9, pp. 504-511, 2006.
24. M. Ohashi, M. S. Runge, F. M. Faraci, and D. D. Heistad, "MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 10, pp. 2331-2336, 2006.
25. M. A. Austin, B. L. Rodriguez, B. McKnight et al. , "Lowdensity lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men, " The American Journal of Cardiology, vol. 86, no. 4, pp. 412-416, 2000.
26. F. N. Brand, D. L. McGee, W. B. Kannel, J. Stokes III, and W. P. Castelli, "Hyperuricemia as a risk factor of coronary heart disease: the Framingham study, " The American Journal of Epidemiology, vol. 121, no. 1, pp. 11-18, 1985.
27. H. Alcaino, D. Greig, M. Chiong et al. , "Serum uric acid correlates with extracellular superoxide dismutase activity in patients with chronic heart failure, " European Journal of Heart Failure, vol. 10, no. 7, pp. 646-651, 2008.